Shanghai Mabgeek Biotech.
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (11)
Phase III Clinical Study of MG-K10 Humanized Mab Injection in Subjects With Prurigo Nodularis
Started: 2/26/2025
Clinical Trial of MG-K10 in Stage III of Moderate to Severe Asthma
Started: 3/25/2025
A Study of MG-K10 in Chronic Spontaneous Urticaria
Started: 4/14/2026
A Phase III Study of MG-K10 in Adolescents With Moderate-to-Severe Atopic Dermatitis
Started: 4/17/2026
A Study to Evaluate the Efficacy and Safety of MG-K10 in Participants Who Have Atopic Dermatitis
Started: 5/1/2026
A Study to Evaluate the Efficacy and Safety of MG-K10 in Adults With Chronic Rhinosinusitis With Nasal Polyps
Started: 10/27/2026
Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic Rhinitis
Started: 3/20/2025
A Study of MG-K10 Humanized Monoclonal Antibody Injection in Subjects With Atopic Dermatitis
Started: 6/30/2025
Study of MG-ZG122 Humanized Monoclonal Antibody in Asthma Subjects
Started: 5/11/2025
A Phase 2 Study of MG-K10 in Chronic Spontaneous Urticaria
Started: 9/23/2026
IB/IIa Study of MG-K10 in Adolescent Moderately Severe Patients
Started: 7/19/2024